SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
March 14, 2007
Date of Report
(Date of Earliest Event Reported)
Commission File No. 01-28911
National Healthcare Technology, Inc.
------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 91-1869677
-------- ----------
(State of Incorporation) (IRS Employer Identification No.)
2525 East Camelback Road Suite 900, Phoenix, AZ 85016
-----------------------------------------------------
(Address of principal executive offices)(Zip Code)
Company's telephone number, including area code: (480) 588-2488
ITEM 5.02 Departure of Directors or Principal Officers; Election of Officers;
Appointment of Principal Officers.
On March 14, 2007, National Healthcare Technology, Inc. (the "Company")
appointed Samuel Plunkett as its CEO and CFO, replacing Jon Carlson, who
previously held those positions and resigned on March 14, 2007. Mr. Carlson also
resigned as a director and Mr. Plunkett was elected to the Board of Directors.
Samuel Plunkett is an attorney in private practice in Beverly Hills, California.
Mr. Plunkett has been licensed in the State of California as an attorney since
1989. Mr. Plunkett has business law experience as well as being a successful
trial lawyer.
Mr. Plunkett received his law degree from Pepperdine University School of Law in
1988 and has a Bachelor of Science in Psychology from Colorado State University.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
March 21, 2007 NATIONAL HEALTHCARE TECHNOLOGY, INC.
/s/ Samuel Plunkett
Samuel Plunkett, CEO